BioPharmCatalyst is an online resource for stock market investors of publicly traded biotech and pharmaceutical companies listed on U.S. markets (NASDAQ and NYSE). A commonly used function of ...

Biotech investors now have on-demand insights into clinical trial data that can improve investment decisions BioPharmCatalyst (BPC), a division of Scientist.com, today announced that members with an ...

SAN DIEGO--(BUSINESS WIRE)--BioPharmCatalyst (BPC), a division of Scientist.com, today announced that members with an “Elite” and “Elite Plus” subscription now get full access to Trial Insights, which ...

Excellent article. As I indicated re Bret Jensen’s excellent presentation on the same subject, it’s easy enough to hedge a position. At a minimum, I would begin to phase in a long position. In fact, ...